Home / Companies / News /  Serum Institute to increase Covishield production next month

The Serum Institute of India will raise production of the AstraZeneca COVID-19 vaccine to about 90 million doses in June from about 65 million a month now, a company spokesman told Reuters on Monday.

This came amid reports of shortage of COVID-19 vaccines in the country as flagged by several state governments.

India is currently using made-in-India vaccines -- Covishield manufactured by SII and Covaxin of Bharat Biotech -- for its COVID-19 vaccination programme. Russian Sputnik V is the third vaccine to get approval from the Drug Controller General of India (DCGI) for emergency use. (A

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.
Recommended For You
Edit Profile
Get alerts on WhatsApp
Set Preferences My ReadsFeedbackRedeem a Gift CardLogout